Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Health partnerships in an era of SDGs

Cancer control in low and middle income countries: New solutions to evolving challenges

Published: 28 Feb 2020

Views: 501

Rating:

Save

Mr Ben Simms - Tropical Health and Education Trust, London, UK

Mr Ben Simms speaks to ecancer at CCLMIC 2019 about the significance of health partnerships in an era of significant development goals (SDGs) and how these are helping to reduce the treatment gap in oncology.

He explains the THET health partnership scheme and the political, ethical and environmental challenges involved with trying to reduce this treatment gap.

Mr Simms emphasises that there are increasing opportunities available for people working in cancer to become involved with health partnerships.

Related Videos

Innovating cancer care access for low and middle-income countries

Lacy Hubbard - Founding President and CEO, Elekta Foundation

Innovating cancer care access for low and middle-income countries ( Lacy Hubbard - Founding President and CEO, Elekta Foundation )

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations

Dr Dario Trapani - European Institute of Oncology, IRCCS, Milan, Italy

Innovation in cancer treatment and equity: ensuring emerging treatments reach all populations ( Dr Dario Trapani - European Institute of Oncology, IRCCS, Milan, Italy )

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

Prostate cancer ( Dr Alison Tree - Institute of Cancer Research, London, UK )

Rectal cancer

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

Rectal cancer ( Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC

Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA

Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC ( Dr Shirish Gadgeel - Henry Ford Cancer Institute, Detroit, USA )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres

Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA)

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres ( Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA) )

Time toxicity: the burden on cancer patients

Dr Arjun Gupta - University of Minnesota, Minneapolis, USA

Time toxicity: the burden on cancer patients ( Dr Arjun Gupta - University of Minnesota, Minneapolis, USA )

More from ecancer